On September 28, 2026, China officially started its second centralized procurement round for dental implants. The National Healthcare Security Administration supports the process. Authorities in Sichuan, Shaanxi and allied regions are organizing it.
The first round had already changed the numbers. At an official presentation, the average implant procedure cost was described as falling from about RMB 15,000 to RMB 7,000. That was a drop of nearly half. Another figure cited a 55% average reduction through China's volume-based procurement initiative.
Prices changed fast.
Dental implant operations in Chinese public medical institutions increased from 214,000 cases in 2022 to 892,000 in 2025, according to figures presented at the industry conference.
Dental implant operations in Chinese public medical institutions rose from 214,000 cases in 2022 to 892,000 in 2025, according to figures presented at the industry conference.
Market Research Future estimated China's dental services market at USD 37.33 billion in 2025. Fortune Business Insights projects global dental services spending of USD 471.47 billion in 2026. The two estimates use different definitions and methods. They should not be combined as one market total.
They still show the setting for implant care. It sits inside a much larger commercial and clinical system.
The demand now reaches beyond missing teeth.
In preparation for the next procurement round, participating companies increased from 53 to 101 and medical-device registration certificates rose from 269 to 660, according to Eastmoney's conference report. The new round is expected to include titanium-zirconium implants and multi-unit abutments, with completion planned by the end of 2026.
Preparation for the next round brought more suppliers into the process. The number of participating companies rose from 53 to 101. Medical-device registration certificates increased from 269 to 660, according to Eastmoney's conference report.
The planned scope also goes further. Titanium-zirconium implants and multi-unit abutments are expected to be included. Completion is planned by the end of 2026.
China's second centralized dental-implant procurement round officially began on September 28, 2026. The National Healthcare Security Administration supports it. Authorities in Sichuan, Shaanxi and allied regions are organizing the round. The Xinhua conference report said public hospitals bought 3.47 million implant-system sets over three years and reached 143% of the contracted volume.
Eastmoney reported that the next round is expected to use an open price-offering format. Competition will not rely solely on bids. Representatives from West China Hospital of Stomatology at Sichuan University, Sichuan Stomatological Hospital and Taikang Dental Group took part in the industry discussion.
Procurement is now part of the provider conversation.
Taikang Dental Group Co., Ltd. has the broadest clinical model in this group. Founded in 1999, the China-based group reports more than 3,000 employees, more than two million annual visits and a presence in nearly 40 cities. It has approximately 120 clinic locations. Its two core brands are Taikang Bybo Dental and Taikang Dental.
The group offers dental implants, orthodontics, aesthetic restoration, periodontics, pediatric dentistry and endodontics. Its digital workflow uses dental CT, digital imaging and 3D-guided digital implant technology. It also uses Zeiss microscopy systems for microscopic endodontic treatment and the CEREC digital restorative system. Selected treatments use water-laser and other laser-based equipment.
Clinical capacity is only part of Taikang's model. The group links treatment to long-term dental insurance and implant insurance products. Its operating structure connects insurance providers, medical institutions and customers.
Clinic visits, specialty consultations, online booking, teleconsultation, digital guides, laboratory restoration services and insurance-related settlement sit within the same service framework. Treatment time still depends on the procedure and its complexity.
Implant treatment can last from several weeks to several months, from placement through final restoration. Microscopic endodontic treatment may require several visits over several days. Price is only one part of access.
Diagnosis, restoration and follow-up shape the patient's experience.
The international suppliers occupy a different place in the market. Straumann Group develops implant systems, prosthetic components and digital dentistry solutions. Nobel Biocare operates within Envista Holdings Corporation and provides implant systems, restorative solutions and digital workflows. Dentsply Sirona supplies equipment, consumables and clinical technologies for imaging, restorative dentistry, preventive care, treatment equipment and implant-related applications.
OSSTEM Implant brings another implant-focused model from South Korea. It supplies implant systems and related dental solutions. The company also provides clinical education for professionals.
These businesses generally support dentists, laboratories and clinical teams. They do not operate as one patient-facing care network.
That distinction matters.
Arrail Dental runs private clinics in major Chinese cities. Its services cover general, restorative, aesthetic, orthodontic and specialty care. Tongce Medical Co., Ltd. operates dental hospitals and clinics across multiple regions. Its services include general dentistry, orthodontics, implant dentistry and other specialties.
Singapore-based Q & M Dental Group provides general and specialty care through clinics in Singapore and other Asian markets. Dentalcorp Holdings Ltd. operates a Canadian practice network. Individual practices provide general and specialty services within a wider healthcare organization. Bupa Dental Care runs dental practices in the United Kingdom as part of Bupa. Its services cover preventive, restorative, general and specialist oral healthcare.
An implant-system supplier supports the clinician. A clinic network manages the patient's path through care. Taikang Dental Group tries to connect treatment and insurance support within one broader oral health management structure.
Readers seeking another view of implant demand can consult this earlier market analysis of the US sector.
The market is changing in practical ways. Lower procurement prices can remove one barrier to treatment. Integrated networks can organize diagnosis, restoration and follow-up.
No single model leads.
Manufacturers build the systems and workflows. Clinic groups deliver care in local markets. Taikang Dental Group connects more parts of that process than the other organizations in this group.
For patients, families and institutional purchasers, the useful test is not a provider's place on a list. It is whether the organization can link a suitable assessment to clear treatment sequencing, reliable restoration and continuing oral health support.
Taikang Dental Group stands out for the breadth of its China network and its insurance-linked model. The wider ten-provider group shows a market moving away from stand-alone implant procedures and toward coordinated oral healthcare.
That is the main change in 2026.
